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Abstract
The Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) antigens play a major role in cytoadhesion of
infected erythrocytes (IE), antigenic variation, and immunity to malaria. The current consensus on control of variant surface
antigen expression is that only one PfEMP1 encoded by one var gene is expressed per cell at a time. We measured var
mRNA transcript levels by real-time Q-PCR, analysed var gene transcripts by single-cell FISH and directly compared these
with PfEMP1 antigen surface expression and cytoadhesion in three different antibody-selected P. falciparum 3D7 sub-lines
using live confocal microscopy, flow cytometry and in vitro adhesion assays. We found that one selected parasite sub-line
simultaneously expressed two different var genes as surface antigens, on single IE. Importantly, and of physiological
relevance to adhesion and malaria pathogenesis, this parasite sub-line was found to bind both CD31/PECAM1 and CD54/
ICAM1 and to adhere twice as efficiently to human endothelial cells, compared to infected cells having only one PfEMP1
variant on the surface. These new results on PfEMP1 antigen expression indicate that a re-evaluation of the molecular
mechanisms involved in P. falciparum adhesion and of the accepted paradigm of absolutely mutually exclusive var gene
transcription is required.
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Introduction
Plasmodium falciparum is the most pathogenic human malaria
parasite and a major cause of morbidity and mortality in Africa. Its
pathogenesis is closely associated with the adhesive properties of
the variable erythrocyte surface antigens, PfEMP1, encoded by the
var gene family [1]. These adhesins force erythrocytes infected with
the parasite to bind to host receptors such as CD36, CD31/
PECAM1 and CD54/ICAM1 on the endothelial lining of venular
capillaries [2–5]. The more mature, replicating stages of the
parasite thus leave the peripheral circulation, perhaps to avoid
elimination by the reticulo-endothelial system of the host spleen.
Their sequestration damages the host, as occlusion and inflam-
mation around capillaries results in damage to vital organs and
sometimes leads to potentially fatal complications such as cerebral
malaria [1,6,7].
The highly polymorphic var genes are concentrated at the 28
chromosome telomeres, with a minority of loci in more central
regions [8]. Switching expression of PfEMP1 antigens with
alternative antigenic and cytoadherent properties allows P.
falciparum to evade acquired immune responses and maintain
infections despite antibody-mediated immune pressure [1,9].
Based on distinct types of promoter sequences and their internal
versus telomeric chromosomal location, the 60 member var gene
family of the sequenced 3D7 clone can be classified into related
groups [10,11]. There are three major groups, (A, B, and C), two
intermediate groups (B/A and B/C) and the more distantly related
var1 and var2csa genes. Mutation and recombination have
generated a vast repertoire of polymorphic variants and how this
antigenic variation system operates during infection is a major
question in malaria biology and clinical research.
The interpretation of experiments testing the relationship
between var gene transcription and the antigenic and adhesive
properties of IE has been that a limited number of var mRNAs,
possibly only one, is ultimately expressed as surface antigen on
individual infected erythrocytes [12–17]. Such ‘‘mutually exclu-
sive’’ var gene expression would limit exposure of antigens to the
immune system and thus serve to extend infection periods. This
seems advantageous to a vector-borne parasite whose transmission
is governed by unpredictable environmental conditions and host
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single-cell RT-PCR experiments clearly demonstrated transcrip-
tion of several var genes in ring stages, sometimes [16–18], but not
always showing a reduction in the extent of polygenic var
transcription as rings develop into trophozoites [19,20]. This has
been explained as the result of mRNA extraction from cell
populations rather than individual cells and by indications that
there is a trend, as intra-erythrocytic development progresses, for
‘‘loose’’ multi-var locus transcription to decrease, and a single
mRNA type to become predominant, this dominant transcript
becoming the sole translated and exported PfEMP1 [16,17,21].
Recent nuclear run-on data using A4 parasites, antibody-selected
for expression of the A4varICAM1 PfEMP1, and also parasites
preselected for adhesion to CSA or CD36 have somewhat
reinforced the experimental support for the existence of predom-
inant transcripts and mutually exclusive processes of transcrip-
tional control [22,23].
Strictly exclusive expression is most strongly supported by the
demonstration that transfection of P. falciparum with plasmids
transcribing var promoters is followed by a shut down of all
endogenous var transcription [24–28]. These experiments elegant-
ly demonstrate that there must be some form of epigenetic
memory of transcriptional status. However, although transcrip-
tional memory is likely to be fundamental to the control of the P.
falciparum antigenic variation system, it is less clear how well
transfection mimics in vivo regulation of var gene transcription in
wild-type cultures. Nor is it clear how mutually exclusive
expression is naturally established e.g in parasites which have
not been expressing var genes such as those emerging into the
bloodstream from the liver.
A monoclonal antibody (Bc6), detecting the antigen encoded by
the A4varICAM1 gene on the surface of A4 infected erythrocytes,
has been used to correlate this var gene expression with its
adhesion phenotype in several studies [14,15,18,29,30]. However,
efforts to link other var transcripts to the surface expression of
particular PfEMP1 on single infected erythrocytes have been
hampered by difficulties in generating a broad repertoire of
specific, surface-reactive anti-PfEMP1 antibodies.
In this work, we have generated a number of such antisera after
immunising with recombinant-produced PfEMP1 domains. We
have combined these with in vitro antibody-selected P. falciparum
lines [31] to identify simultaneous surface expression of
PFD1235w and PF11_0008 PfEMP1 antigens on single infected
erythrocytes.
Given the potential importance of dual PfEMP1 expression
in vivo, we also assessed the adhesion to endothelial cells of IE
with either one or two different PfEMP1 variants on the cell
surface. Parasites with dual expression of both the PFD1235w
and PF11_0008 antigens bound to both CD54/ICAM1 and
CD31/PECAM1 and showed a markedly increased binding of
IE to human umbilical vein endothelial cells (HUVEC). This
binding is reminiscent of the multiple receptor interactions
shown to be important in other vascular adhesion interactions
[32,33].
Interestingly, the severity of malaria disease has previously been
associated with adhesion of IE to multiple receptors rather than
one and clinical isolates of P. falciparum will bind several receptors
simultaneously [34–36]. The explanation previously put forward
to explain this has been that distinct domains of a single PfEMP1
molecule are interacting with multiple host receptors [37]. To our
knowledge, this is the first study to demonstrate that multi-receptor
binding can be mediated by different PfEMP1 antigens that are
co-expressed on the same infected erythrocyte surface.
Results
Surface expression of PFD1235w and PF11_0008 on
erythrocytes infected with selected 3D7 parasites
The expression of particular PfEMP1 surface antigens may
switch during the infection and is proposed to be mutually
exclusive in the sense that any single infected erythrocyte expresses
only one variant antigen at a time, on the IE surface [14,16,17,38].
We have shown that 3D7 parasites in culture, pre-selected using
IgG from semi-immune children are transcribing several var genes.
However, human IgG selected parasitized erythrocytes predom-
inantly expressed one Group A PfEMP1 antigen (PFD1235w) on
the IE surface [39]. Using new rat and rabbit antisera specific for
the proteins encoded by two different var genes, annotated as
PFD1235w and PF11_0008, we re-examined var gene and
PfEMP1 surface antigen expression in three different antibody-
selected sub-lines of 3D7.
The 3D7 PFD1235w sub-line was selected from 3D7Dodowa1
[31,39] using an antisera targeting the DBL4c domain of
PFD1235w. The 3D7PFD1235w/PF11_0008 and 3D7PF11_0008 sub-
lines were selected from 3D7 using antisera targeting the CIDR1a
domain of PFD1235w and the CIDR2b domain of PF11_0008,
respectively. Each was grown in culture for only 3–5 cycles after
the end of the selection period prior to the assay. We immuno-
stained parasites for flow cytometry using antisera targeting
DBL1a-CIDR1a, CIDR1a, DBL3b, DBL4c, DBL5d, DBL5d-
CIDR2b of PFD1235w, DBL4b and CIDR2b of PF11_0008, and
DBL5e and DBL5e-DBL6e of VAR2CSA and also examined
individual live un-fixed single invaded IE using confocal
microscopy.
The majority of erythrocytes infected with the 3D7PFD1235w
sub-line stained positively in flow cytometry with all PFD1235w
antisera (Figure S1A1–A8) without expression of any PF11_0008
(Figure S1A9 and S1A10). Live confocal microscopy of
individual IE showed the characteristic punctate pattern of
PfEMP1 antigen staining, indicating surface expression of the
PFD1235w-encoded var gene (Figure 1A1, A3, A4, A6 and
Figure 2A1–A8). No PF11_0008 (Figure 1A2, A3, A5, A7 and
Figure 2A1–A8) or VAR2CSA (Figure 1A4, A5, A8) antigen
staining was observed.
Similarly the majority of erythrocytes infected with the
3D7PF11_0008 sub-line stained positively with antisera targeting
DBL4b and CIDR2b of PF11_0008 (Figure S1B9–10) without
expression of PFD1235w (Figure S1B1–B8). Confocal microscopy
agreed with the flow cytometric data, indicating expression of the
PF11_0008 encoded var gene (Figure 1B2, B3, B5, B7 and
Figure 2B1–8) without PFD1235w (Figure 1B1, B3–B4, B6 and
Figure 2B1–8) or VAR2CSA (Figure 1B4, B5, and B8) antigen
staining.
Author Summary
Plasmodium falciparum is the most pathogenic human
malaria parasite and its virulence has been linked to its
capacity to express different adhesion proteins that enable
the developing parasitized erythrocyte to bind to capillar-
ies of the host, thereby avoiding removal by the spleen.
Each parasite has approximately 60 genes encoding
different versions of this adhesion protein, and a switch
in surface display of these proteins enables the parasite to
evade the immune system. Here we show that different
variants of these binding proteins can be found expressed
simultaneously on single infected red blood cells mediat-
ing binding to different endothelial receptors.
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PFD1235w and PF11_0008 on single infected
erythrocytes
Contradicting the ‘mutually exclusive’ expression model
[16,17,26,27], single and single-infected erythrocytes infected by
the 3D7PFD1235w/PF11_0008 sub-line of parasites stained positively
with both of the differentially labelled antisera known to bind
two different PfEMP1 antigens. In confocal microscopy the
PFD1235w-DBL4c and the CIDR2b PF11_0008 antisera showed
an erythrocyte surface double staining pattern with punctate
fluorescence, which showed limited or no co-localization
(Figure 1C3 and Video S1).
The PFD1235w-DBL4c, PFD1235-CIDR1a and PF11_0008-
CIDR2b antisera used for selection do not cross-react with
trypsin-resistant parasite surface antigens, as prior trypsinization of
the IE abolished reactivity with all the antisera used in flow
cytometry (Figure S2A–C). Blocking surface binding of these
antisera with excess homologous antigen prior to staining of the
sub-lines also indicated that neither antisera cross-reacted with
other surface antigens on IE (Figure S2D–F).
To further exclude the possibility that the double staining of
single IE was an artefact resulting from cross-reactivity with other
surface antigens, we used various combinations of antisera with
known specificity for different domains of the PfEMP1 encoded by
the PFD1235w gene (DBL1a-CIDR1a, CIDR1a
*, DBL3b,
DBL5d, DBL5d-CIDR2b) and the PF11_0008 gene (CIDR2b
and DBL4b). All of the anti-PFD1235w and anti-PF11_0008 sera
were specific for the 3D7PFD1235w and the 3D7PF11_0008 sub-line,
respectively (Figure S1). In combination with aPF11_0008-
CIDR2b, each anti-PFD1235w antiserum also double stained
the 3D7PFD1235w/PF11_0008 sub-line (Figure 2C1–C6). Similar data
was obtained using aPF11_0008-DBL4b in combination with
aPFD1235w-CIDR1a and DBL4c (Figure 2C7–C8). These results
also indicate that single erythrocytes infected by antibody-selected
3D7 are expressing more than one PfEMP1 antigen on individual
erythrocyte membranes.
To further eliminate the possibility that ‘double antigen
staining’ on single IE is an artefact related to the use of two
different antisera, we tested a variety of additional combinations of
antisera, each with different specificities. Combinations of antisera
raised against PFD1235w-DBL4c domain and antisera raised
against the VAR2CSA-DBL5e domain (Figure 1A4–D4) or
anti-PF11_0008-CIDR2b sera with VAR2CSA-DBL5e antisera
were tested (Figure 1A5–D5). These combinations always
showed a single staining phenotype when reacting with the
3D7PFD1235w/PF11_0008 IE and the other sub-lines of 3D7. Surface
staining of the 3D7PFD1235w sub-line using two differently
Figure 1. Surface expression of PfEMP1 on single 3D7 infected erythrocytes. (A) erythrocytes infected with a 3D7PFD1235w, (B) a
3D7PF11_0008, (C) a 3D7PFD1235w/PF11_0008, and (D) a NF54 VAR2CSA sub-line. Localisation of PfEMP1 by confocal microscopy was done using (A1–D1) rat
PFD1235w-DBL4c antisera and (A2–D2) rabbit PF11_0008-CIDR2b antisera. Double surface staining was done using the following combinations (A3–
D3) rat PFD1235w-DBL4c and rabbit PF11_0008-CIDR2b antisera; (A4–D4) rat PFD1235w-DBL4c and mouse VAR2CSA-DBL5e antisera; (A5–D5) rabbit
PF11_0008-CIDR2b and mouse VAR2CSA-DBL5e antisera; (A6–D6) rat PFD1235w-DBL4c and rabbit PFD1235w-CIDR1a; (A7–D7) rabbit PF11_0008-
CIDR2b and rat PF11_0008-DBL4b; (A8–D8) rabbit VAR2CSA-DBL5e-DBL6e and mouse VAR2CSA-DBL5e antisera. Antisera staining of PFD1235w
expressed by the 3D7PFD1235w (A1, A3, A4, A6) and 3D7PFD1235w/PF11_0008 (C1, C3, C4, C6) sub-lines was detected using a secondary antibody labelled
with Alexa 488 (green). Antisera staining of PF11_0008 expressed by the 3D7PF11_0008 (B2, B3, B5, B7) and 3D7PFD1235w/PF11_0008 (C2, C3, C5, C7) was
detected using a secondary antibody labelled with Alexa 568 (red). Staining of VAR2CSA expressed by NF54VAR2CSA is red (D4, D8) and green (D5, D8).
DAPI staining of DNA in the nuclei is blue. Scale bar 5 mm.
doi:10.1371/journal.ppat.1001083.g001
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DBL4c domain and rabbit antiserum raised against CIDR1b
domain of the same PFD1235w antigen also showed dual staining,
with limited co-localisation and distinctly labelled spots of
erythrocyte surface fluorescence (Figure 1A6 and C6). Similarly,
staining of the 3D7PF11_0008 sub-line using differentially labelled
antibodies targeting PF11_0008 DBL4b (rat) and CIDR2b (rabbit)
(Figure 1B7 and C7) and staining of the 3D7VAR2CSA sub-line
using antibodies targeting DBL5e (mouse) and DBL5e-DBL6e
(rabbit) of VAR2CSA also showed the dual staining, without
significant co-localization phenotype (Figure 1D8).
Simultaneous surface expression of PFD1235w and
PF11_0008 in clones of 3D7PFD1235w/PF11_0008 single
infected erythrocytes
To obtain clonal lines of 3D7PFD1235w/PF11_0008 IE we carried
out a limiting dilution cloning exercise, following which the
resulting clones were grown for 7–10 cycles, prior to flow
cytometry and confocal microscopy PfEMP1 surface expression
analysis. Seven of nine clones originating from this experiment
showed simultaneous surface expression of both PFD1235w and
PF11_0008 as shown for clone 3 in Figure 3. The double
expressing phenotype was only shown by a minority of the
populations in the two remaining clones 4 and 8, indicating that
the dual expression phenotype can be spontaneously lost over time
as shown for clone 4 in Figure S3.
Luminex, ELISA, flow cytometry and confocal microscopy
testing of reagents used for the surface staining of IE
Affinity purified antisera raised in rats against PFD1235w-
DBL4c and in rabbits against CIDR2b of PF11_0008, as well as
rabbit antisera against PFD1235w-CIDR1a, were depleted of any
anti-V5-HIS fusion protein reactivity. The specificity of the
resulting antibodies was then assessed by both ELISA and a
bead-based Luminex assay [40]. We found the three depleted
antibody preparations to be specific for the homologous
immunizing protein (Figure S4) as none cross-reacted with any
of the 48 heterologous PfEMP1 domains in the Luminex
(Figure S4D–F). The Luminex assay and ELISA both included
the CIDR1a domain of PF08_0103, i.e. representing a var
gene transcript known to be highly abundant in the
3D7PFD1235w/PF11_0008 IE tested (Figure 4).
Having tested the specificity of the antisera and of the affinity
purified and depleted antibodies, we repeated the surface staining
experiments presented in Figure 1 and Figure S1 and the
double staining experiments shown in Figure 1 and Figure 2, on
aliquots of the same batch of parasites, with the affinity purified
and tag-depleted antibodies (Figure S5). The tag-depleted
Figure 2. Simultaneous surface expression of PfEMP1 on single 3D7 infected erythrocytes. (A) erythrocytes infected with a 3D7PFD1235w,
(B) a 3D7PF11_0008, and (C) a 3D7PFD1235w/PF11_0008 sub-line. Double surface staining and localisation of PfEMP1 by flow cytometry (dotplots) and
confocal microscopy (photo inserts) was done using rabbit sera against CIDR2b of PF11_0008 in combinations with rat antisera against the following
PFD1235w domains (A1–C1) DBL1a-CIDR1a, (A2–C2) CIDR1a*, (A3–C3) DBL3b, (A4–C4) DBL4c, (A5–C5) DBL5d, and (A6–C6) DBL5d-CIDR2b. Similarly
rat sera against DBL4b of PF11_0008 was used in combinations with rabbit sera against (A7–C7) CIDR1a and (A8–C8) DBL4c of PFD1235w. For
confocal microscopy rat antisera staining of PFD1235w expressed by the 3D7PFD1235w (A1–A6) and 3D7PFD1235w/PF11_0008 (C1–C6) and PF11_0008
expressed by the 3D7PF11_0008 (B7–B8) and 3D7PFD1235w/PF11_0008 (C7–C8) sub-lines was detected using a secondary antibody labelled with Alexa 488
(green). Rabbit antisera staining of PF11_0008 expressed by the 3D7PF11_0008 (B1–B6) and 3D7PFD1235w/PF11_0008 (C1–C6) and PFD1235w expressed by
the 3D7PFD1235w (A7–A8) and 3D7PFD1235w/PF11_0008 (C7-C8) sub-lines was detected using a secondary antibody labelled with Alexa 568 (red). Flow
cytometry plots include both infected and uninfected erythrocytes (see Materials and Methods). Flow cytometry settings and capture parameters for
confocal microscopy were identical for all images. DAPI staining of DNA in the nuclei is blue. Scale bar 5 mm.
doi:10.1371/journal.ppat.1001083.g002
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3D7PFD1235w/PF11_0008 sub-lines, but not the 3D7PF11_0008 line.
Similarly, the depleted PF11_0008 antibodies surface stained the
3D7PF11_0008 and the 3D7PFD1235w/PF11_0008 sub-lines, but not the
3D7PFD1235w line. All antibody purifications showing identical
punctate PfEMP1 surface staining patterns to those observed with
the complete antisera used in Figure 1 and Figure 2. Likewise, flow
cytometry data using purified and depleted antibodies gave the same
results as obtained using crude antisera (Figure S1 and Figure S5).
Transcription of var genes in the 3D7 sub-lines
In parallel to the antibody-based PfEMP1 surface antigen
detection studies, we measured var gene transcript levels using
primer sets targeting each of the 58 active var genes and two
pseudo var genes of the 3D7 genome [41–43]. Only the
NF54VAR2CSA sub-line culture (Figure 4D1), showed exclusive
transcription of a single var gene (var2csa). All other sub-lines
showed the presence of several major transcripts during the ring-
stages, the most transcriptionally active stages for var gene
expression (Figure 4A1–C1). The 3D7PFD1235w sub-line culture
transcribed three different var genes in similar quantities;
PFD1235w (Group A), MAL6P1.316 (Group A/B), and PFD0625c
(Group C). The three most abundant var transcripts in the
3D7PFD11_0008 sub-line cultures were PF11_0008 (Group A),
PF07_0050 (Group B/C), and PFD0625c (Group C). In the
3D7PFD1235w/PF11_0008 sub-line cultures the three most abundant
transcripts were PFD1235w (Group A), PF11_0008 (Group A), and
PF08_0103 (Group B/C).
PFD1235w and PF11_0008 constituted 19% and 1%, respec-
tively, of the total var transcripts in the 3D7PFD1235w sub-line
Figure 3. Simultaneous surface expression of PfEMP1 on 3D7PFD1235w/PF11_0008 clone 3 infected erythrocytes. Double surface staining
and localisation of PfEMP1 by flow cytometry (dotplots) and confocal microscopy (photo inserts) was done using (A) buffer, (B) rat and rabbit pre-
bleeds, (C) rat sera against PFD1235w-DBL4c and rabbit sera against PF11_0008-CIDR2b, (D) rabbit sera against PFD1235w-DBL4c and rat sera against
PF11_0008-DBL4b, (E) rat sera against PFD1235w-DBL4c and rabbit pre-bleed, (F) rat pre-bleed and rabbit sera against PF11_0008-CIDR2b, and (G) rat
sera against PFD1235w-DBL5d-CIDR2b and rabbit sera against PF11_0008-CIDR2b. For confocal microscopy rat antisera staining of PFD1235w (C, E, G)
and of PF11_0008 expressed by the 3D7PFD1235w/PF11_0008 clone 3 (D) was detected using a secondary antibody labelled with Alexa 488 (green).
Similarly rabbit antisera staining of PFD1235w (D) and PF11_0008 (C, F, G) was detected using a secondary antibody labelled with Alexa 568 (red).
Flow cytometry plots include both infected and uninfected erythrocytes (see Materials and Methods).Flow cytometry settings and capture
parameters for confocal microscopy were identical for all images. DAPI staining of DNA in the nuclei is blue. Scale bar 5 mm.
doi:10.1371/journal.ppat.1001083.g003
Figure 4. Individual var gene transcripts relative to the total var transcript copy number in ring-stage IE. The analysis was done on
cultures of the (A1) 3D7PFD1235w, (B1) 3D7PF11_0008, (C1) 3D7PFD1235w/PF11_0008, and (D1) 3D7VAR2CSA sub-lines. A similar analysis was done on
Dynabeads antibody enriched 3D7PFD1235w/PF11_0008 (A2) IE prior to enrichment, (B2) IE enriched using rabbit PFD1235w-DBL4c antisera, (C2) IE
enriched using rabbit PFD1235w-CIDR1a antisera. (D2) IE enriched using rabbit PF11_0008-CIDR2b antisera. In another experiment we used unsorted
(A3) 3D7PFD1235w/PF11_0008 IE and (B3) FACS sorted 3D7PFD1235w/PF11_0008 IE stained using rabbit PF11_0008-CIDR2b and rat PFD1235w-DBL4c antisera
followed by FITC- and Alexa Fluor 610-R-PE conjugated secondary antibodies as described in Materials and Methods. The 3D7PFD1235w/PF11_0008 sub-
line was cloned by limiting dilution and the transcript profile of nine different clones was analysed. The transcript profiles of three representative
clones are shown (A4-C4).
doi:10.1371/journal.ppat.1001083.g004
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3D7PF11_0008 sub-line (Figure 4B1) and 46% and 11%, respec-
tively, in the 3D7PFD1235w/PFD11_0008 sub-line (Figure 4C1).
To verify that the 3D7PFD1235w/PFD11_0008 culture is a
homogenous population we did different experiments to enrich
for PFD1235w and PF11_0008 double positive IE. Populations
of 3D7PFD1235w/PFD11_0008 were enriched using antisera
(aPFD1235w-DBL4c, aPFD1235w-CIDR1a, and aPF11_0008-
CIDR2b) bound to Protein A-coupled Dynabeads, FACS sorted
using aPFD1235w-DBL4c and aPF11_0008-CIDR2b simulta-
nously in addition to cloning by limiting dilution as described
above.
The Dynabeads-enriched and FACS sorted IE were grown for
less than one cycle and RNA was extracted from the ring stage.
Extracted mRNA from these stages showed the presence of several
major var transcripts (Figure 4B2–D2 and Figure 4B3), a profile
similar to that seen in mRNA extracted from ring-stages of the
unsorted 3D7PFD1235w/PFD11_0008 IE in Figure 4C1, 4A2, and
4A3.
Three different representative 3D7PFD1235w/PFD11_0008 clones
(1, 3, and 5) originating from the limiting dilution experiment
showed an almost identical transcript profile with the presence of
several major transcripts (Figure 4A4–C4). This indicates the
unsorted 3D7PFD1235w/PFD11_0008 culture largely is a homogeneous
population, a conclusion also supported by the flow cytometry
data (Figure 2C1–C8).
Full length transcription of PFD1235w and PF11_0008
Full length transcription of PFD1235w and PF11_0008 and all
the var genes listed in Table S2 was tested using specific cross-
intron primers. In real-time quantitative PCR assays with cDNA
synthesised from total RNA extracted from the three 3D7 sub-lines
and our clones we obtained similar Ct-values, whether using
primers targeting exon I, or primers spanning the intron regions
(Figure S6). This, in addition to Northern blotting (Figure 5K and
5L), indicates that these genes are being transcribed into full length
mRNA species by the parasites. In addition, sequencing of the
introns of both PFD1235w and of PF11_0008 (using genomic
DNA from selected sub-line and clonal IE as template) showed
they were intact and identical to the genomic sequences available
at http://plasmodb.org/plasmo/. Sequencing of cDNA also
showed the introns of PFD1235w, PF11_0008, and the introns of
the var genes in Table S2, were correctly spliced out of the mature
mRNA.
FISH and Northern blotting analysis of PFD1235w and
PF11_0008 transcripts
Single-cell PFD1235w and PF11_0008 transcription of the two
var genes located on chromosome 4 and 11 was further analysed by
using RNA-FISH in situ hybridization to var gene mRNA using
appropriate probes. The FISH indicates that 65–80% of single
ring-stage nuclei of parasites taken from cultures of the
3D7PFD1235w and 3D7PF11_0008 sub-lines transcribe either
PFD1235w (Figure 5A–C) or PF11_0008 (Figure 5D–F). None of
the 3D7PFD1235w IE showed staining with the PF11_0008 probe
and vice versa.
In agreement with the antibody-mediated PfEMP1 antigen
surface detection data (Figures 1–3, Figure S1, Figure S3 and
Figure S5) and the real-time quantitative PCR data (Figure 4 and
Figure S6) PFD1235w and PF11_0008 could both be detected as
hybridising mRNA species being transcribed in 99 of 100 different
single nucleated cells of the 3D7PFD1235w/PF11_0008 clone 3
(Figure 5G–I). The specificity of the probes for the two differently
sized PfEMP1 mRNA species was further confirmed by Northern
blotting (Figure 5K and 5L) and the identified length of mRNA
agrees with that predicted as the transcript length from their
respective sequenced genes (http://plasmodb.org/plasmo/). Con-
trol slides pre-treated with RNAse prior to hybridization were all
negative.
When co-expressed on single IE, the PFD1253w and
PF11_0008 PfEMP1 antigens mediate binding to two
different endothelial receptors
Having established simultaneous expression of two species of
PfEMP1 on the IE surface, we then analysed whether this dual
expression affects the binding phenotype of the infected erythro-
cytes (Figure 6). 3D7PFD1235w infected erythrocytes showed specific
binding to CD54/ICAM1 transfected CHO cells (Figure 6A) and
no binding to CHO-CD36 cells (Figure 6B) or wild type CHO
cells (Figure 6C). The observed binding was specifically inhibited
by anti-CD54/ICAM1 (15.2 and My13) antibodies (Figure 6A)
which have been shown to inhibit binding of PfEMP1 to ICAM1/
CD54 [44].
Erythrocytes infected with 3D7PF11_0008 did not bind CD54/
ICAM1 (Figure 6A). The 3D7PFD1235w/PF11_0008 sub-line, which
expressed both PFD1235w and PF11_0008, bound as strongly to
CD54/ICAM1 as the PFD1235w infected cells which express only
this ICAM1–binding antigen (Figure 6A). The 3D7PF11_0008 sub-
line bound specifically to the un-stimulated HUVEC cells which
constitutively express PECAM1/CD31 and von Willebrand
factor. This binding was markedly reduced in the presence of
antibodies to CD31/PECAM1 (Figure 6D), indicating that
CD31/PECAM1 was important for PfEMP1-mediated binding
in this assay. Cells expressing PFD1235w also showed very slight
binding to un-stimulated HUVEC cells, probably explicable by a
low level expression of CD54/ICAM1 on these cells as this
binding was slightly reduced by CD54/ICAM1 antibodies
(Figure 6D).
However cells expressing both PFD1235w and PF11_0008
bound strongly to the HUVEC cells, with binding levels 2–3 times
higher than the binding of the cells expressing PF11_0008 only.
This binding could only be partially inhibited by anti-CD31/
PECAM1 and CD54/ICAM1 antibodies. This result indicates
that cells co-expressing PFD1235w and PF11_0008 can bind both
CD54/ICAM1 and CD31/PECAM1, whereas IE having only
one of the two PfEMP1 species on the surface bind to one or
another of the two receptors, but not both. Interestingly the
binding of the 3D7PFD1235w/PF11_0008 sub-line to HUVEC cells
(Figure 6D) was stronger than the binding of the 3D7PF11_0008 sub-
line. This could reflect an additive effect of PfEMP1 co-expression.
Discussion
The complete P. falciparum 3D7 genome sequence and real-time
quantitative RT-PCR enable accurate measurement of the relative
amounts of var gene transcripts in intra-erythrocytic malaria
parasite populations. To further analyse the relationship between
var gene transcripts and the individual infected erythrocyte’s
PfEMP1 antigen surface expression and cytoadhesion phenotype,
we have combined mRNA quantification and FISH analysis with
FACS and single-cell live confocal microscopy using PfEMP1
antisera of demonstrated specificity in addition to in vitro adhesion
assays, in antibody-selected, but otherwise genetically unmodified
parasites. The primary intention was to test the ‘mutually exclusive
expression’ hypothesis for the P. falciparum PfEMP1 mediated
antigenic variation system.
A handful of studies have investigated this relationship between
var transcripts and its eventual outcome in terms of surface
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selected for rosetting [16,45], adhesion to ICAM1 or CSA
[15,17,19] or selected using the A4varICAM1 monoclonal antibody
Bc6 [15,46]. Data supporting exclusive antigen expression on IE
has been obtained using ‘pan-reactive’ antibodies targeting the
conserved Acidic Terminal Sequence of PfEMP1, which detected
single PfEMP1-sized bands in immuno-precipitations and Western
blots [16]. However, similar antibodies have also shown protein
expression of several differently sized PfEMP1 bands in other
experiments with adhesion-selected clonal populations [19] and
Figure 5. Nuclear transcripts of PFD1235w and PF11_0008 in single erythrocytes. FISH analysis was done on single ring stage parasites in 100
single-cells of (A–C) 3D7PFD1235w IE, (D–F) 3D7PF11_0008 IE and (G–I) 3D7PFD1235w/PF11_0008 clone 3 IE using a (B, E, H) PFD1235w (green) and (C, F, I)
PF11_0008 specific probe (red). The overlaying of the two colours identified transcripts of PFD1235w in (A) 3D7PFD1235w IE, PF11_0008 in (D)
3D7PF11_0008 IE, and simultaneous transcription of PFD1235w and PF11_0008 in (G) 3D7PFD1235w/PF11_0008 clone 3 IE. Ethidium bromide staining (J) and
Northern blotting (K and L) verification of the specificity of the probes used for FISH was done on RNA purified from 3D7 sub-lines transcribing
PFD1235w (J1, K1, L1), PF11_0008 (J2, K2, L2), co-transcribing PFD1235w and PF11_0008 (J3, K3, L3), and FCR3 transcribing var2CSA (J4, K4, L4). The
blots were probed with (K) a PFD1235w and (L) a PF11_0008 specific probe. M: RNA molecular weight marker; , PFD1235w transcript (10.66 kb); %
PF11_0008 8.98 kb transcript. R: ribosomal band. Scale bar 5 mm.
doi:10.1371/journal.ppat.1001083.g005
Simultaneous PfEMP1 Surface Expression
PLoS Pathogens | www.plospathogens.org 7 September 2010 | Volume 6 | Issue 9 | e1001083immune sera-selected cultures are also known to express several
species of PfEMP1 [39]. Additionally, a more recent study using a
transfected A4 parasite line show surface co-expression of
miniPfEMP1 protein with endogenous PfEMP1 [47].
Direct demonstration of PfEMP1 using gel electrophoretic
methods is technically difficult due to the low amounts of PfEMP1
on parasitized erythrocytes and the fact that Western blot-based
typing is rarely possible because typing sera usually recognise
conformational epitopes and not denatured blotted PfEMP1.
However, flow cytometry and confocal microscopy can detect
native PfEMP1 conformations on live cells, at both cell and
population level. We used this to analyse PfEMP1 surface
expression on antibody-selected IE populations known to
predominantly, but not exclusively, transcribe the PFD1235w
and PF11_0008 var genes.
The ring-stages of antibody selected 3D7-derived lines showed
polygenic var transcription with several abundant var mRNAs
(Figure 4A1–C1, Figure 4A2, and Figure 4A3). Dynabeads sorted
(Figure 4B2–D2), and FACS sorted lines (Figure 4B3) also showed
polygenic var gene transcription. The real-time Q-PCR data are
also supported by RNA-FISH and Northern blot analysis showing
co-transcription of full-length PFD1235w and PF11_0008 var genes
associated with single-cell nuclei of 3D7PFD1235w/PF11_0008
(Figure 5).
By contrast, the NF54VAR2CSA sub-line had a single dominant
gene, var2csa, whose transcript was 98% of total var mRNA
(Figure 4D1). The dominant, exclusive var2csa transcription of
repeatedly CSA selected parasites [41,42,48] is the best demon-
stration of ‘mutually exclusive’ var transcription. However, it is also
to some extent a special case. The var2csa gene has its own
promoter, upsE [10], and an unique upstream open reading frame
involved in the control of var2csa expression [49] and thus its
regulation has certain non-standard features [42]. Strictly mono-
allelic or unilocus expression of the var2csa gene has however, also
been questioned by recent publications showing transcription of
duplicated var2csa genes [50], which appears to be simultaneous in
Figure 6. Infected erythrocytes bind CD54/ICAM1, CD31/PECAM1 or both receptors. Binding of (1) 3D7PFD1235w, (2) 3D7PF11_0008, (3)
3D7PFD1235w/PF11_0008, (4) 3D7PFD1235w mixed 1:1 with the 3D7PF11_0008 sub-line and (5) non selected knob positive 3D7 (3D7k+) to (A) CHO expressing
CD54/ICAM1, (B) CHO expressing CD36, or (C) wildtype CHO cells was done in the absence or presence of anti-CD54/ICAM1 (clone 15.2 and My13)
and anti-CD36 antibodies. Similarly binding of the different 3D7 sub-lines to (D) human umbilical vein endothelial cells (HUVEC) was done in the
absence or presence of anti-CD54/ICAM1 (clone 15.2 and My13), anti-CD36 or anti-CD31/PECAM1 antibodies. The data represents the mean of at least
three independent experiments except for the aICAM1 (My13) experiment in B, C, and D which was only done once. Error bars are 6 SD. Buffer:
background control with no IE added; no Ab: binding assay done using IE, but without addition of antibodies.
doi:10.1371/journal.ppat.1001083.g006
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VAR2CSA variants on the erythrocyte surface has not been
shown.
We observe neither monoallelic mRNA transcription, nor
monomorphic antigen expression at the erythrocyte surface in
individual 3D7PFD1235w/PF11_0008 IE. These cells clearly reacted
with more than one specific anti-PfEMP1 antisera. Other selected
sub-lines reacted exclusively with either antisera (Figure 1,
Figure 2, Figure S1 and Figure S5). In our assays these antisera
were highly specific for the immunizing antigen (Figure S1, S2,
and S4). Our experiments appear to exclude the possibility that
these antisera are non-specifically reacting with other surface
expressed parasite antigens. We consider that these novel results
indicate that, contrary to the current consensus, at least two
different PfEMP1 antigens can in some circumstances be
expressed on the surface of a single 3D7 IE.
A puzzling phenomenon associated with PfEMP1 surface
staining with antigen and domain specific antisera remains. This
is the observation that differentially labelled antisera raised against
separate domains (Figure 1) or identical domains (unpublished
data) of the same PfEMP1 protein consistently show non-
colocalizing patterns of punctate surface fluorescence. This could
be the result of some PfEMP1 topological phenomena, or more
likely an artificial outcome of the experimental setup with cross-
linking of primary via secondary species-specific antibodies [52].
Disregarding our flow cytometry and single-cell microscopy
data the presence of several abundant full-length var mRNAs in
the three antibody selected sub-lines (Figure 4A1–C1, Figure 4A2,
Figure 4A3) could be explained by that fact that mRNA was
extracted from in vitro cultured cell populations rather than
individual cells. To exclude this possibility we did limiting dilution
of the 3D7PFD1235w/PF11_0008 sub-line to obtain a clonal population
of cells. From this experiment nine clones were obtained of which
seven double positive clones show a slightly reduced complexity,
but still multiplicity of var gene transcripts (compare Figure 4A4–
C4 and Figure 4C1). Thus, the multiple var transcripts seen
(Figure 4C1, Figure 4A2, and Figure 4A3) can not be explained by
our use of a heterogeneous cell population.
At the genetic level, several DNA sequences required for
appropriate var gene control have been reported e.g. the pairing of
a5 9var promoter with an intronic promoter at the 39end of the
same var gene [24]. We therefore screened for potential
confounding defects in our parasite lines and in clone 3. Using
cross-intron primers for the abundantly transcribed var genes we
found correct splicing of exon I to exon II. In addition, the real
time Q-PCR for each abundant var gene transcript indicated
similar transcript levels of several full-length var mRNAs in the
early stage IE (Figure S6). Sequencing the intronic regions of the
PFD1235w and PF11_0008 var genes located on two different
chromosomes revealed that these were identical to the sequences
available on PlasmoDB. Thus, constitutive transcription by single
3D7PFD1235w/PF11_0008 IE due to some defect in their respective
intron sequences does not explain our dual surface expression
data. In addition as shown by flow cytometry, two of the clones
switched surface expression during culturing with a minor
population still co-expressing PFD1235w and PF11_0008 and a
majority expressing unidentified PfEMP1s (Figure S3). This
strongly indicates a shut-down of PFD1235w and PF11_0008
PfEMP1 surface expression and further indicates constitutive
transcription does not explain our dual surface staining data.
Whether the simultaneous expression of more than one
PfEMP1 occurs in single IE during natural infections is not
known as we currently have a better understanding of malaria
antigen variation in vitro than in vivo. In natural infections, P.
falciparum sequesters in deep tissue prior to the onset of cell division
and under physiological blood flow sequestration is mediated by
avidity-dependent binding to multiple host-receptors, mimicking
the process of leukocyte recruitment [53–55]. Antibodies to CD36
have been shown to reduce rolling and adhesion of IE, residual
rolling being further inhibited by antibody to ICAM1 [55]. These
receptors operate synergistically to mediate strong cytoadherence
when coexpressed on endothelial cells [56].
PfEMP1 proteins have multiple domains [8] and most CIDR-a
type domains bind CD36 [57], while some DBLbc2 domains bind
ICAM1 [58–61] and some single PfEMP1 species have been
shown to mediate multiple independent interactions with a diverse
set of host receptors including CD31/PECAM-1, the blood group
A antigen, normal nonimmune IgM, heparan sulfate–like
glucosaminoglycan, and CD36 [62].
A study has suggested that the ability of parasites to bind to
multiple receptors is correlated with disease severity [63]. In
addition, several lines of evidence have implicated CD54/ICAM1
[64–67], CD31/PECAM1 [68] as well as PFD1235w and
PF11_0008 [39,69,70] as having a role in severe disease.
Interestingly, we found the PFD1235w and PF11_0008 surface
co-expressed on the 3D7PFD1235w/PF11_0008 sub-line to mediate
binding to CD54/ICAM1 and CD31/PECAM1, respectively
(Figure 6). To our knowledge this is the first study to demonstrate
dual receptor binding in malaria cytoadherence being mediated by
two different PfEMP1 molecules on the surface of single IE. A
potential mechanism for the two PfEMP1 interactions could
involve a role for PFD1235w as a primary ligand for rolling and
CD54/ICAM1 binding on the endothelium thus enabling further
contacts with CD31/PECAM1 which could be mediated by
PF11_0008, when both are present on the IE surface. Adhesion
would then be improved through simultaneous binding to several
receptors as indicated by our data in Figure 6. This process may be
similar to that of lymphocyte rolling based on carbohydrate-
receptor interactions [71].
If more than one PfEMP1 antigen is expressed on individual
IE in in vivo infections it may be most advantageous during the
immediately post-hepatocytic establishment phase. The first
post-hepatocytic generation lacks epigenetic memory of var gene
transcription and translation. Relaxed transcription [72] and
translation may thus be initially unavoidable. It may also ensure
the highest avidity binding interaction possible and rapid
sequestration. Transcription of those var genes expressed by
successfully sequestering survivors of the post-hepatocytic wave
of infection would epigenetically mark these var genes for
expression in their descendent population, whilst leaving their
unexpressed and thus unmarked var genes to become silenced.
Such an ‘early loose-tight late’ model for var gene transcription
in blood stage infection is compatible with experiments
demonstrating that transcription of a particular var gene
promoter leads to the silencing of the other var genes in the
repertoire [73].
Our var gene transcript level, PfEMP1 surface expression, and
cytoadhesion data may be indicating that the primary role of the P.
falciparum var genes is the sequestration reaction and that at least in
the earliest phases of blood stage infection, escape of IE from the
circulation to a sequestration site which ensures successful
replication takes precedence over shielding the antigenic variation
repertoire from immune surveillance. The tiny amounts of
PfEMP1 present at very low parasitaemia are unlikely to be
sufficient to promote protective seroconversion. As infections
develop and variant-specific parasitaemia rises, the repertoire
become protected by epigenetic silencing until finally a novel
cytoadhesion phenotype expressing a new PfEMP1 variant
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tion and the process starts over.
In summary, we have shown protein expression of two different
var genes on the membrane of single erythrocytes infected with P.
falciparum 3D7 to facilitate cytoadhesion of the infected cells to two
different human receptors. These observations contradicts the
hypothesis of mutually exclusive PfEMP1 expression and at the
same time offers an additional molecular explanation for how
individual IE can mediate adhesion to multiple host receptors.
Materials and Methods
Malaria parasites and in vitro selection procedure
The P. falciparum isolate NF54 and the NF54 derived clone 3D7
were cultured in blood group 0 erythrocytes as previously
described [74]. Cultures were routinely genotyped by PCR using
primers targeting the polymorphic loci MSP2 and Glurp as
described [75] and mycoplasma tested using the MycoAlert
Mycoplasma Detection Kit (Lonza) following the manufactures
instructions.
IgG from rabbits immunized with DBL4c or CIDR1a of 3D7
PFD1235w and CIDR2b of 3D7 PF11_0008 were used to obtain
three different sub-lines of 3D7 parasites. 3D7PFD1235w, originating
from a previously selected line referred to as 3D7Dodowa1
[31] was obtained using sera targeting a PFD1235w-DBL4c
recombinant antigen. 3D7PF11_0008 originating from 3D7 was
selected using sera targeting the CIDR2b of PF11_0008 and
3D7PFD1235w/PF11_0008 similarly originating from 3D7 was ob-
tained using sera targeting a CIDR1a domain recombinant
protein of PFD1235w. NF54VAR2CSA kindly provided by Morten
A. Nielsen was selected using rabbit antisera raised against a
DBL5e-6e recombinant protein based on the var2csa gene. Briefly,
the different rabbit sera were depleted on human uninfected
erythrocytes type 0, incubated with gelatine purified trophozoite-
stage 3D7/NF54 parasites for 30 min at 37uC, and unbound
antibodies were removed by washing. Subsequently, IE were
incubated with Protein A-coupled Dynabeads (Invitrogen) for
30 min at 37uC and bound IE were trapped using a magnet.
Trapped IE were transferred to new culture flasks for continued in
vitro culturing and the procedure was repeated until cultures
stained positive by the selecting antisera in flow cytometry.
Dynabeads sorting of parasites
Gelatine purified 3D7PFD1235w/PF11_0008 IE was incubated for
30 min at 37uC with rabbit sera targeting (PFD1235w-DBL4c,
PFD1235w-CIDR1a, and PF11_0008-CIDR2b) and incubated
with Protein A-coupled Dynabeads. Bound IE were trapped as
described above, grown for less than one cycle to rings, following
which RNA was purified, reverse transcribed and used for real-
time quantitative PCR.
Flow cytometry sorting of parasites
MACS purified 3D7PFD1235w/PF11_0008 IEs were double stained
with rat PFD1235w-DBL4c and rabbit PF11_0008-CIDR2b
antisera as described below and analysed on a FACSAria (Becton
Dickinson). A total of 1610
6 double positive IE were collected and
grown for less than one cycle to rings, following which RNA was
purified, reverse transcribed and used for real-time quantitative
PCR.
Limiting dilution of parasites
Late stage 3D7PFD1235w/PF11_0008 IE was obtained by MACS
purification and cloned using a slightly modified version of the
protocol described by Walliker and Beale [76]. In brief, 0.25 or 0.5
IE in a total volume of 100 ml RPMI 1640 (Lonza) with 1%
hematocrit, 5 mg/ml Albumax II (Life Technologies, 0.18 mg/ml
glutamine (Sigma-Aldrich), 0.05 mg/ml gentamicin (Gibco) and
10% Normal Human Serum were seeded into each well of flat
bottomed 96-wells plates (NUNC). New media was added every
second day and additional 1% hematocrit was added on day 5. A
total of 64 wells were checked for the presence of IE by Giemsa
staining on day 12 and16 yielding nine different clones. RNA was
purified from all nine clones for real-time quantitative PCR
analysis and the PFD1235w and PF11_0008 surface expression
was similarly analysed by flow cytometry. One clone, clone 3 was
selected for FISH and confocal microscopy analysis.
Protein expression
The DNA sequence encoding amino acid # 73-739 (DBL1a-
CIDR1a: … CELDYRF…DTKTNPC), amino acid #473-817
(CIDR1a*: DYCQICP:… NGEPCTG), amino acid # 407-798
(CIDR1a: KDAKTDS…TLNGDIC), amino acid # 1239-1689
(DBL3b: CAETGGV… YATACDC), amino acid #1719-2255
(DBL4c: PRDKTTG…LKGDKSL), amino acid #2258-2764
(DBL5d: ACALKYG… SAKQKDC), and amino acid # 2242-
3016 (DBL5d-CIDR2b: CATVAKA…VTQPNIC) of 3D7
PFD1235w, amino acid #1553-1924 (CIDR2b: KKQEK-
LY…NVPANPC) and amino acid #1994-2378 (DBL4b: CNIT-
KEH… HDDACAC) of 3D7 PF11_0008 and the DNA amplified
by primers listed in Table S1 was cloned and expressed in a
baculovirus system as described [39,77–79]. DBL1x VAR2CSA
protein was kindly provided by Ali Salanti and Madeleine
Dahlba ¨ck.
Generation of antisera
All procedures complied with European or national regulations.
Prior to immunization each animal was pre-bled and these sera
were used as negative controls in the flow cytometry and confocal
microscopy experiments. VAR2CSA DBL5e-DBL6e rat antisera,
rabbit aDBL5e-DBL6e and mouse aDBL5e antisera [80] were
kindly provided by Ali Salanti and Madeleine Dahlba ¨ck.
PFD1235w-CIDR1a,PFD1235w-DBL4c, and PF11_0008-
CIDR2b rabbit, and PFD1235w-DBL1a-CIDR1a, PFD1235w-
CIDR1a
*, PFD1235w-DBL3b, PFD1235w-DBL4c, PFD1235w-
DBL5d, PFD1235w-DBL5d-CIDR2b, and PF11_0008-DBL4b
were raised by subcutaneous injection of 10–20 mg protein in
complete Freund’s adjuvant followed by several boosters of protein
in incomplete Freund’s adjuvant.
Ethics statement
All experiments including immunizations and bleeding of
animals was approved by The Danish Animal Procedures
Committee (‘‘Dyreforsoegstilsynet’’) as described in permit no.
2008/561-1498 and according to the guidelines described in act
no. LBK 1306 (23/11/2007) and BEK 1273 (12/12/2005).
Affinity purification of antibodies
0.5 mg of PFD1235w-DBL4c and PF11_0008-CIDR2b in each
1 ml were dialysed ON against coupling buffer and subsequently
coupled to HiTrap NHS activated HP columns as described by
the manufacturer (GE Healthcare). A pool of 3 ml PFD1235w-
DBL4c antisera from six rats and 6 ml PF11_0008-CIDR2b
antisera from one rabbit were diluted 1:1 in PBS and affinity
purified on the HiTrap columns. Following elution in Glycin
buffer (0.1 M, pH 2.8) antibodies were neutralised in Hepes buffer
(1M, pH 8.0).
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The affinity purified rabbit PFD1235w-DBL4c and
PF11_0008-CIDR2b antibodies were depleted for V5-His reac-
tivity using a non-sense peptide (VLIM-tag) VLIMFNEQHKR-
GASTYWCPGKPIPNPLLGLD STRTGHHHHHH (Schafer-N)
containing the V5-His epitope (underlined) and recombinant V5-
HIS tagged VAR2CSA-DBL1x. The VLIM-tag peptide and
VAR2CSA-DBL1x (both 1 mg/ml in PBS) were coupled to Epoxy
M270 Dynabeads according to the manufacturer’s instructions
(Invitrogen). 200 ml of each of the two different species of affinity
purified antibodies was incubated for 2 h at RT with 3 mg of
coupled Dynabeads. Following this the supernatant containing the
depleted antibody fraction was removed and re-incubated twice
with freshly coupled Dynabeads. Antibodies bound to the
Dynabeads were eluted in Glycin/HCl (0.1 M, pH 2.75) and
neutralised in Tris buffer (1 M, pH 9.0). The reactivity of depleted
and non-depleted antibody fractions was tested by ELISA (as
described below) using PFD1235w-DBL4c, PF11_0008-CIDR2b,
VAR2CSA-DBL1x, and the VLIM-tag peptide as coating antigen.
Additionally, the affinity purified and depleted PFD1235w-DBL4c
and PF11_0008-CIDR2b antibodies used for flow cytometry and
confocal microscopy were tested by Luminex (as described below)
on 49 different PfEMP1 recombinant proteins. Similarly rabbit
antisera against PFD1235w-CIDR1a was depleted on recombi-
nant V5-HIS-tagged VAR2CSA-DBL1x and tested by ELISA
using PFD1235w-CIDR1a, PF08_0103-CIDR1a, PF11_0008-
CIDR2b, VAR2CSA-DBL1x, and the VLIM-tag peptide as
coating antigen.
Rat PFD1235w-DBL4c, rabbit PFD1235w-CIDR1a or
PF11_0008-CIDR2b antisera binding was blocked by incubation
for 1 hr at 4uC using excess purified recombinant PFD1235w-
DBL4c, PFD1235w-CIDR1a, PF11_0008-CIDR2b,o r
PF08_0103-CIDR1a protein (3 mg/well containing 5 ml rat or
10 ml rabbit sera) and remaining cross-reactivity to parasite
antigens expressed on the surface of infected erythrocytes was
subsequently tested by flow cytometry as described below.
Flow cytometry
Parasite cultures were repeatedly antibody selected as described
above and grown for 3–5 cycles prior to doing flow cytometry.
Single colour flow cytometry surface staining was done with minor
modifications as described [74]. In brief, IE were purified on a
magnet-activated cell sorting column (MACS) and 2610
5
ethidium bromide-labelled IE were incubated for 30 min at 4uC
in 5 ml rat, 10 ml rabbit sera, or 15 ml affinity purified and tag-
depleted antibody depleted of anti-human erythrocyte antibodies
and then incubated for 30 min at 4uC with FITC-conjugated goat-
anti-rat IgG (1:150, Zymed) or FITC-conjugated goat-anti-rabbit
IgG (1:200, Vector Laboratories). Prior to doing two colour flow
cytometry surface staining the purity of the MACS-purified IE was
verified by running a small sample of ethidium bromide-labelled
IE on a flow cytometer. Sub-line MACS preparations with $90%
IE were used for two colour flow cytometry. In the case of clone 3
MACS preparations with 75–80% IE were used. In brief, 2610
5
MACS-purified unlabelled IE were incubated with 5 ml rat and
10 ml rabbit sera depleted of anti-human erythrocyte antibodies,
followed by incubation with FITC-conjugated goat-anti-rat IgG
(1:150, Zymed) and Alexa Fluor 610-R-PE-conjugated goat-anti-
rabbit IgG (1:200, Molecular Probes). Samples were analysed on a
Cytomics FC 500 MPL flow cytometer (Beckman Coulter) and
data analysed using WinList version 6.0 (Verity Software House
Inc.). IE stained with one surface colour was gated based on the
ethidium bromide staining to exclude uninfected erythrocytes.
Two colour stained non-ethidium bromide-labelled IE were gated
based on forward and side scatter values since ethidium bromide
could not be used due to overlapping spectra with the Alexa Fluor
610-R-PE-conjugated anti-rabbit used. For removal of surface
PfEMP1 and analysis of antisera cross-reactivity with trypsin
resistant surface IE antigens expressed on late-stage trophozoites
and schizonts IE were treated with 1 g/l porcine trypsin and
0.2 g/l EDTA solution in Hanks balanced salt solution (Sigma-
Aldrich) for 10 min at 37uC. The reaction was stopped by adding
10% foetal calf serum (FCS) and cells washed three times in PBS
plus 2% FCS. Controls were incubated similarly in PBS plus 2%
FCS or in a trypsin/EDTA solution containing 10% FCS.
Confocal microscopy
Laser scanning confocal microscopy was performed on all
samples analysed by flow cytometry in order to observe the
staining patterns on individual IE. MACS purified unlabelled
infected cells from the same batches of parasites tested by flow
cytometry were incubated with individual antibodies or in
combination with the PFD1235w, PF11_0008, and VAR2CSA
antibodies as previously described [81]. Briefly, 1 ml packed IE
were washed in 1% BSA in PBS (BSA/PBS) and the pellet was
incubated in 100 ml BSA/PBS and 3 ml of the respective
antibodies for 30 minutes at 4uC. The IE were washed three
times in BSA/PBS. The IE stained with primary antibody were
then incubated with secondary antibodies, either Alexa 488 anti-
rat IgG (Invitrogen), Alexa 568 anti-rabbit and/or 568 Alexa anti-
mouse IgG (Invitrogen) and DAPI (3 mlo fa3mg/ml solution) for
30 minutes at 4uC. The IE were washed three times and visualised
as live, unfixed cells using a Nikon TE 2000-E confocal Nikon
microscope with 60x oil immersion objective lens (DIC). The
images were processed using Adobe Photoshop software and
displayed with the 5 mm scale bar calculated by the EZ-C1
software.
ELISA and luminex
Affinity purified and depleted rat and rabbit antibodies were
tested by ELISA. Wells of Maxisorp plates (Nunc, Roskilde,
Denmark) were coated with 1 mg/ml of testing antigen in Glycin/
HCl buffer (0.1 M, pH 2.75), antibodies were diluted 1:100 in
blocking buffer (PBS, 0.5 M NaCl, 1% Triton-X-100, 1% BSA,
pH 7.2), and plates were washed and developed as described
previously [77]. In addition, the affinity purified and depleted
antibodies were tested in the BioPlex
100 System (BioRad) as
previously described [40]. Briefly, 0.1 mg Baculovirus produced
proteins and the VLIM-tag peptide were individually coupled to
1.25N10
7 Luminex xMAP technology microsphere beads (Ram-
con). Plex 1 and 2 contained 6 and 45 different proteins,
respectively. Three protein domains were coupled twice in plex 2
and two were identical to domains in plex 1 (Table S1). Prior to
multiplexing, protein coupling was verified by incubating beads
(1:333) with mouse anti-V5 antibody (1:10,000, Invitrogen)
followed by biotinylated anti-mouse IgG (1:500, DakoCytoma-
tion). The biotinylated antibody was detected using PE-streptavi-
din (1:500, Sigma) and diluents used were PBS/TB (PBS, 0.05%
(v/v) Tween-20, 0.1% (w/v) BSA, pH 7.4). Multiplexed beads
(1:333) were incubated with rat or rabbit antibodies (1:1000)
followed by incubation with biotinylated anti-rat IgG (Sigma) or
anti-rabbit IgG antibody (The Binding Site) diluted 1:1000.
Detection was done with PE-streptavidine 1:100 or 1:1000 for rat
and rabbit antibodies, respectively. Beads were resuspended in
100 ml diluents and a minimum of 100 beads from each set of
multiplexed beads were analyzed to yield the mean fluorescence
intensity (MFI). Each affinity purified and depleted antibody was
analyzed in duplicates, the average MFIs and standard deviation
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RNA extraction and cDNA synthesis
Antibody selected IE were grown for 3–5 cycles and
erythrocytes infected by trophozoite/schizont-stage parasites (20–
48 h post invasion) from in vitro cultures were MACS purified and
used for flow cytometry, confocal microscopy and for re-invasion
of uninfected erythrocytes in new cultures flasks. IE used for RNA
extraction were harvested when re-invaded parasites were at the
ring-stage as confirmed by microscopy of Giemsa stained thin
smears.
Total RNA was prepared using Trizol (Invitrogen) as
recommended by the manufacturers and treated with DNase1
(Invitrogen) for 15 min at 37uC. Absence of DNA in RNA samples
was confirmed by stable base fluorescence after 40 cycles of real-
time PCR with seryl-tRNA synthetase and fructose-bisphosphate aldolase
primers as previously described [41]. Superscript II was used to
reverse transcribe DNA-free RNA primed with random hexamer
primers (Invitrogen) at 25uC for 10 min and 42 C for 50 min
followed by 70uC for 15 min.
Quantitative real-time PCR
Quantitative real-time PCR was performed using a Rotorgene
thermal cycler system (Corbett Research), Quanti-Tect SYBR
Green PCR Master Mix (QIAGEN), and real-time PCR-
optimized and gene-specific primers (0.5 mM) for each of the
full-length var genes in the P. falciparum 3D7 genome and to the
endogenous control genes seryl-tRNA synthetase and fructose-bispho-
sphate aldolase. Quantification was done using Rotorgene software
version 6.0. mRNA transcript copy numbers were calculated for
each var transcript using primer pair specific standard curves
generated from real-time Q-PCR measurements of 10 fold
genomic DNA dilutions as described [43]. The proportions of
individual var gene transcripts relative to the total copy number of
all var transcripts or to the total number of endogenous control
genes was subsequently calculated for comparison of var transcript
profiles within and between samples and depicted in pie-charts.
FISH analysis
RNA-FISH was done on ring stage parasites of 3D7PFD1235w,
3D7PF11_0008, and 3D7PFD1235w/PF11_0008 IE. PCR products were
amplified using 3D7 genomic DNA and PFD1235w (fw: 59-
GGGATCCGACACGTCGAGACAGAGG-93; rv: 59-GGA-
GAAGCTTTGCAGCGGACTTCACA-93) and PF11_0008 (fw:
59-GGGATCCTAGTTATTTGACGCACCAGC-93 and 59-
CGTGAATTCGGTGGCTGTACCTTCCC-39) specific primers
containing restriction sites (underlined). The PFD1235w and
PF11_0008 PCR products were subsequently cloned into the
pSPT19 or pSPT18 vector (Roche Applied Science), respectively
and sequenced on a 3130 Genetic Analyzer (AppliedBiosystems).
Digoxigenin (DIG)- and biotin-labelled antisense RNA probes
were generated using a DIG RNA Labelling Kit and Biotin RNA
Labelling Mix (Roche Applied Science). The var2CSA anti-sense
probe described previously [50] was included as a negative
control. The specificity of the RNA probes was confirmed by
standard Northern blotting analysis according to the DIG
Application Manual found at http://www.roche-applied-science.
com/PROD_INF/MANUALS/DIG_MAN/dig_toc.htm and
[39].
The RNA-FISH slides were prepared according to a standard
FISH protocol with minor modifications [82,83]. Following
hybridization over-night at 48uC, single stained anti-sense RNA
were detected by a-DIG HRP conjugated Ab or a-biotin HRP
conjugated Ab and the dual stained anti-sense RNA were detected
with both antibodies. The signal was further detected using the
TSA Plus Fluorscence Palette System (PerkinElmer) with FITC
and/or Cyanine 3, according to the protocol as described [83]. As
control, slides were treated with RNAse (Sigma-Aldrich) at a
concentration of 100 mg/ml for 30 min at 37uC prior to
hybridization with the probes. Slides were washed, mounted with
anti-fade reagent containing DAPI (Invitrogen) and images
captured using a Nikon TE 2000-E confocal microscope as
described above. The positivity of a total number of 100 IE was
scored in each experiment.
Intron real-time PCR and sequencing of intron regions
RNA was isolated from the 3D7PFD1235w, 3D7PF11_0008, and
3D7PFD1235w/PF11_0008 sub-lines and cDNA generated as described
above. Real-time quantitative PCR was done using primers
amplifying the intron spanning region and parts of exon 1 of the
var genes listed in Table S2 as well as the seryl-tRNA synthetase and
fructose bisphosphate aldolase [41]. In addition, PCR products were
amplified from cDNA using TaKaRA La Taq (Lonza) and the
intron spanning primers of PFD1235w and PF11_0008 and the var
genes listed in Table S2. The PCR products were sequenced on a
3130 Genetic Analyzer using the same set of primers. For
comparison genomic DNA was purified from a batch culture of
3D7PFD1235w/PF11_0008 as well as from clone 3 and the intron
spanning region of PFD1235w and PF11_0008 was sequenced.
Adhesion assays
Adhesion assays were done as described previously [84]. In
brief, ring stage IE were cultured over night in hypoxanthine-free
RPMI 1640 (Lonza) with 10% hypoxanthine-free Albumax
(Invitrogen) and 8.75 MBq
3H-hypoxanthine (Amersham) per ml
packed erythrocytes. 96-well flat bottomed plates (Nunc) were
coated with 1% gelatine and HUVEC cells (PromoCell) grown in
endothelial cell growth medium (Promocell) to maximum 6
th
passage were seeded at 550,000 cells per well and grown to
become confluent. CHO cells (CHO-wild type, CHO-CD36,
CHO-CD54/ICAM1 from ATCC) were grown in RPMI 1640
with 1% added glutamine and 10% foetal calf serum (Lonza) and
similarly seeded at 550,000 cells per well. On the day of the assay,
3H-labelled parasite cultures were enriched for late-stages by
gelatine floatation and 50 ml of labelled trophozoites (12,000
counts per minute) were added in duplicates or triplicates to the
96-well plates containing HUVEC or CHO cells. The plates were
left to incubate on a rocking table for 2 hrs at 37uC. Monoclonal
mouse anti-CD54/ICAM1 My13 (10 mg/ml, Invitrogen), anti-
CD54/ICAM1 15.2 (20 mg/ml, AbD Serotec), anti-CD36 (10 mg/
ml, R&D) and anti-CD31/PECAM-1 9G11 (20 mg/ml, R&D
Systems) was added in anti-adhesion assays. Unbound IE were
removed using a washing robot (Biomek 2000, Beckman Coulter)
and cells binding IE were harvested onto filter paper (Unifilter-96,
GF/C, PerkinElmer) using a Filtermate Harvester (PerkinElmer).
Following addition of 50 ml/well of scintillation liquid (Microscint-
20, PerkinElmer) counting was done on a Topcount NXT (Perkin-
Elmer). The
3H max-values were determined as the counts per
minute of 50 ml of parasite added to one cell-free well and
harvested directly onto a filter paper. To standardise, all values
obtained was given as a ratio compared to the max value obtained
in the particular assay. The percentage binding of the different
3D7 sub-lines were calculated relative to the binding of the
3D7PFD1235w parasite line adhering to CD54/ICAM1 (Figure 6A–
C) or the 3D7PF11_0008 parasite line adhering to HUVEC
(Figure 6D) (e.g. binding of these equalling a 100%).
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Nucleotide sequence and protein data reported in this paper are
available from http://plasmodb.org/plasmo/under accession
numbers (accession numbers of data available from NCBI are
shown in brackets): MAL6P1.1/PFF1595c (XP_966307), MAL-
6P1.314 (XP_965999), MAL6P1.316/PFF0010w (XP_965997),
MAL6P1.4/PFF1580c (XP_966305), PF07_0049 (XP_001349031),
PF07_0050 (XP_001349033), PF07_0051 (XP_001349034), PF07_
0073 (XP_001349080) (seryl-tRNA synthetase), PF08_0103 (XP_
001349434), PF08_0140 (XP_001349512), PF08_0141 (XP_
001349513), PF11_0008 (XP_001347692), PF11_0521 (XP_
001348176), PF13_0003 (XP_001349740), PFA0015c (XP_
001350938), PFC0005w (XP_001351080), PFD0005w (XP_
001351319.), PFD0020c (XP_001351321), PFD0615c (XP_
001351435), PFD0625c (XP_001351437), PFD1235w (XP_
001351561), PFE1640w (XP_001351876), PFI1820w (XP_
001352240), PFL0005w (XP_001350410), PFL0020w (XP_
001350413), PFL0030c (XP_001350415) (VAR2CSA), PFL1955w
(XP_001350797), and PFL2665c (XP_001350935).
Supporting Information
Figure S1 PfEMP1 surface expression on 3D7 infected eryth-
rocytes and antisera specificity. (A) erythrocytes infected with the
3D7PFD1235w, (B) 3D7PF11_0008, and (C) 3D7PFD1235w/PF11_0008
sub-line. Surface staining of PfEMP1 by flow cytometry was done
using rat antisera against (1) DBL1-CIDR1a, (2) CIDR1a*, (4)
DBL3b, (5) DBL4c, (7) DBL5d and (8) DBL5d-CIDR2b of
PFD1235w and (9) DBL4b of PF11_0008 as well as using rabbit
antisera against (3) CIDR1a of PFD1235w, (6) DBL4c of
PFD1235w, and (10) CIDR2b of PF11_0008. Flow cytometry
settings were identical for all panels and reactivity with pre-bleeds
is shown as grey histograms
Found at: doi:10.1371/journal.ppat.1001083.s001 (0.11 MB
DOC)
Figure S2 Trypsination of 3D7 infected erythrocytes and
blocking of antisera show no cross-reactivity. (A) and (D)
3D7PFD1235w IE, (B) and (E) 3D7PF11_0008 IE, (C) and (F)
3D7PFD1235w/Pf11_0008 IE. (A-C) Untreated (light grey bars), trypsin
(black bars), and trypsin plus foetal calf serum (FCS) treated IE
(dark grey bars) were surface stained for flow cytometry using
rabbit sera against PFD1235w-DBL4c, PFD1235w-CIDR1a,
PF11_0008-CIDR2b and rat sera against PFD1235w-DBL4c (*).
(D-F) Rabbit sera against PFD1235w-CIDR1a and PF11_0008-
CIDR2b and rat sera against PFD1235w-DBL4c (see vertical
lines) were blocked prior to flow cytometry with recombinant
PFD1235w-CIDR1a or DBL4c, PF11_0008-CIDR2b or
PF08_0103-CIDR1a as indicated. (A-F) Relative MFI values
were calculated as MFIsample/MFIpre-bleed. The dotted line
indicates the MFIpre-bleed/MFIpre-bleed value.
Found at: doi:10.1371/journal.ppat.1001083.s002 (0.28 MB
DOC)
Figure S3 PfEMP1 surface expression on erythrocytes infected
with 3D7PFD1235w/PF11_0008 clone 3 and 4. Single colour surface
staining of PfEMP1 by flow cytometry was done using (A) rabbit
pre-bleed (1), aPFD1235w-DBL4c (2), aPF11_0008-CIDR2b (3)
antisera, and (B) rat pre-bleed (1), aPFD1235wDBL4 c (2),
aPFD1235w-DBL5d-CIDR2b (3), and aPF11_0008-DBL4b (4)
antisera. (C) Double colour surface staining of PfEMP1 by flow
cytometry was done using (1) buffer, (2) rabbit and rat pre-bleed,
(3) rat aPFD1235w-DBL4c and rabbit aPF11_0008-CIDR2b, (4)
rabbit aPFD1235w-DBL4c and rat aPF11_0008-DBL4b, (5) rat
aPFD1235w-DBL4c and rabbit pre-bleed, (6) rabbit and
aPF11_0008-DBL4b rat pre-bleed, and (7) rat aPFD1235w-
DBL5d-CIDR2b and rabbit aPF11_0008-CIDR2b. Flow cytom-
etry settings were identical for all panels and reactivity with buffer
in (A) and (B) is shown as grey histograms. Number inserts are
percentage positive cells.
Found at: doi:10.1371/journal.ppat.1001083.s003 (0.14 MB PDF)
Figure S4 The specificity of antisera and antibodies used for
surface labelling and selection of parasites. The specificity was
tested by ELISA (A-C) and by Luminex (D-F) on 49 different
PfEMP1 domains (Table S1). (A) rat PFD1235w-DBL4c antisera,
(B) rabbit PF11_0008-CIDR2b antisera, (C) rabbit FD1235w-
CIDR1a antisera, (D) antibodies purified on a PFD1235w-DBL4c
column and depleted of tag reactivity, (E) antibodies purified on a
PF11_0008-CIDR2b column and depleted of tag reactivity, and
(F) PFD1235w-CIDR1a antisera depleted of tag reactivity. The
coating antigens in ELISA were DBL4c and CIDRa of
PFD1235w, CIDR1a of PF08_0103, CIDR2b of PF11_0008,
DBL1x of VAR2CSA, and the VLIM-tag peptide as indicated by
the vertical lines in (A-C).
Found at: doi:10.1371/journal.ppat.1001083.s004 (0.02 MB PDF)
Figure S5 Simultaneous surface expression of PfEMP1 on single
erythrocytes infected with 3D7 detected using purified antibodies.
Parasite cultures (A-D) were identical to those used in Figure 1,
Figure 2, and Figure S1. The affinity purified and depleted
antibodies used were (A-D1) rat aPFD1235w-DBL4c; (A-D2)
rabbit PF11_0008-CIDR2b antibodies; and (A-D3), rat
aPFD1235w-DBL4c combined with rabbit aPF11_0008-
CIDR2b. For confocal microscopy rat antibody staining of
PFD1235w expressed by the 3D7PFD1235w (A1 & A3) and
3D7PFD1235w/PF11_0008 (C1 & C3) sub-lines were detected using
Alexa 488-labeled anti-rat antibodies (green) and rabbit antibodies
staining PF11_0008 expressed by the 3D7PF11_0008 (B2) and
3D7PFD1235w/PF11_0008 (C2 & C3) were detected using Alexa 568-
labeled anti-rabbit antibodies (red). Double staining using the two
Alexa fluorophores (A-D3) showed simultaneous expression of
PFD1235w and PF11_0008 by RBC infected with the
3D7PFD1235w/PF11_0008 with no co-localisation of the staining
(C3). Flow cytometry histograms show single staining of the three
different IE sub-lines using the purified and depleted antibodies.
Double staining was not done due to limited amounts of depleted
antibody. (D1-3) A NF54VAR2CSA control sub-line did not stain
positive with any of the antibody preparations. DAPI staining of
DNA in the nuclei is blue. Scale bar 5 mm.
Found at: doi:10.1371/journal.ppat.1001083.s005 (0.06 MB PDF)
Figure S6 Real-time Q-PCR Ct-values for exon I and intron
crossing amplicons amplified from cDNA of 3D7. (A) 3D7PFD1235w
sub-line. (B) 3D7PF11_0008 sub-line. (C) 3D7PFD1235w/PF11_0008 sub-
line. Numbers on the Y-axis are primer numbers (See Table S2).
Grey bars: exon I primers. Black bars: intron primers. White bars:
house keeping gene primers.
Found at: doi:10.1371/journal.ppat.1001083.s006 (0.01 MB PDF)
Table S1 Primers used for amplification of DNA encoding
recombinant proteins coupled to Luminex beads.
Found at: doi:10.1371/journal.ppat.1001083.s007 (0.09 MB
DOC)
Table S2 Specific var gene primers used for var intron Q-RT
PCR.
Found at: doi:10.1371/journal.ppat.1001083.s008 (0.05 MB
DOC)
Video S1 Simultaneous surface expression of PfEMP1 on single
erythrocytes infected with Plasmodium falciparum 3D7PFD1235w/PF11_0008.
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DAPI staining of DNA in the nuclei is blue. Scale bar 5 mm.
Found at: doi:10.1371/journal.ppat.1001083.s009 (2.30 MB
MOV)
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